Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Endocr Relat Cancer. 2014 Jul 10;21(5):705–714. doi: 10.1530/ERC-14-0173

Figure 2.

Figure 2

The majority of evaluable treated patients showed improvement over baseline that was present 2 or more weeks. Only 1 placebo patient showed improvement over baseline, while the remaining 4 placebo patients showed increasing BM frequency.